rs2319974

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_006785.4(MALT1):​c.*1395A>G variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.111 in 216,282 control chromosomes in the GnomAD database, including 2,304 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.13 ( 2029 hom., cov: 33)
Exomes 𝑓: 0.070 ( 275 hom. )

Consequence

MALT1
NM_006785.4 3_prime_UTR

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -3.09

Publications

3 publications found
Variant links:
Genes affected
MALT1 (HGNC:6819): (MALT1 paracaspase) This gene encodes a caspase-like protease that plays a role in BCL10-induced activation of NF-kappaB. The protein is a component of the CARMA1-BCL10-MALT1 (CBM) signalosome that triggers NF-kappaB signaling and lymphoctye activation following antigen-receptor stimulation. Mutations in this gene result in immunodeficiency 12 (IMD12). This gene has been found to be recurrently rearranged in chromosomal translocations with other genes in mucosa-associated lymphoid tissue lymphomas, including a t(11;18)(q21;q21) translocation with the baculoviral IAP repeat-containing protein 3 (also known as apoptosis inhibitor 2) locus [BIRC3(API2)-MALT1], and a t(14;18)(q32;q21) translocation with the immunoglobulin heavy chain locus (IGH-MALT1). Alternatively spliced transcript variants have been described for this gene. [provided by RefSeq, May 2018]
MALT1 Gene-Disease associations (from GenCC):
  • combined immunodeficiency due to MALT1 deficiency
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, Ambry Genetics, ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.92).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.288 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
MALT1NM_006785.4 linkc.*1395A>G 3_prime_UTR_variant Exon 17 of 17 ENST00000649217.2 NP_006776.1 Q9UDY8-1A8K5S1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
MALT1ENST00000649217.2 linkc.*1395A>G 3_prime_UTR_variant Exon 17 of 17 NM_006785.4 ENSP00000497997.1 Q9UDY8-1

Frequencies

GnomAD3 genomes
AF:
0.128
AC:
19522
AN:
152100
Hom.:
2026
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.293
Gnomad AMI
AF:
0.0110
Gnomad AMR
AF:
0.0843
Gnomad ASJ
AF:
0.0236
Gnomad EAS
AF:
0.0717
Gnomad SAS
AF:
0.0147
Gnomad FIN
AF:
0.122
Gnomad MID
AF:
0.0823
Gnomad NFE
AF:
0.0595
Gnomad OTH
AF:
0.0995
GnomAD4 exome
AF:
0.0702
AC:
4496
AN:
64064
Hom.:
275
Cov.:
0
AF XY:
0.0673
AC XY:
1993
AN XY:
29610
show subpopulations
African (AFR)
AF:
0.312
AC:
921
AN:
2952
American (AMR)
AF:
0.0887
AC:
174
AN:
1962
Ashkenazi Jewish (ASJ)
AF:
0.0263
AC:
107
AN:
4068
East Asian (EAS)
AF:
0.0780
AC:
717
AN:
9196
South Asian (SAS)
AF:
0.0126
AC:
7
AN:
554
European-Finnish (FIN)
AF:
0.225
AC:
9
AN:
40
Middle Eastern (MID)
AF:
0.0363
AC:
14
AN:
386
European-Non Finnish (NFE)
AF:
0.0538
AC:
2123
AN:
39496
Other (OTH)
AF:
0.0784
AC:
424
AN:
5410
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
201
402
604
805
1006
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.129
AC:
19561
AN:
152218
Hom.:
2029
Cov.:
33
AF XY:
0.129
AC XY:
9609
AN XY:
74432
show subpopulations
African (AFR)
AF:
0.293
AC:
12150
AN:
41512
American (AMR)
AF:
0.0844
AC:
1290
AN:
15288
Ashkenazi Jewish (ASJ)
AF:
0.0236
AC:
82
AN:
3472
East Asian (EAS)
AF:
0.0716
AC:
372
AN:
5192
South Asian (SAS)
AF:
0.0149
AC:
72
AN:
4830
European-Finnish (FIN)
AF:
0.122
AC:
1298
AN:
10602
Middle Eastern (MID)
AF:
0.0850
AC:
25
AN:
294
European-Non Finnish (NFE)
AF:
0.0595
AC:
4048
AN:
68004
Other (OTH)
AF:
0.101
AC:
214
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
801
1602
2403
3204
4005
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
196
392
588
784
980
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0646
Hom.:
589
Bravo
AF:
0.135
Asia WGS
AF:
0.0800
AC:
280
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.92
CADD
Benign
0.79
DANN
Benign
0.54
PhyloP100
-3.1
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2319974; hg19: chr18-56416469; API